HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.

AbstractBACKGROUND:
Extracellular nucleotides released in conditions of cell stress alert the immune system from tissue injury or inflammation. We hypothesized that the P2X7 receptor (P2X7-R) could regulate key elements in inflammatory bowel disease pathogenesis.
METHODS:
Colonoscopy samples obtained from patients with Crohn's disease (CD), ulcerative colitis, and controls were used to analyze P2X7-R expression by RT and real-time PCR, immunohistochemistry, and confocal microscopy. Inflammatory response was determined by the levels of cytokines by enzyme-linked immunosorbent assay in cultures of intestinal explants. Apoptosis was determined by the TUNEL assay. P2X7-R C57BL/6 mice were treated with trinitrobenzene sulfonic acid or dextran sulfate sodium (DSS) for inducing colitis.
RESULTS:
P2X7-R was expressed in higher levels in inflamed CD epithelium and lamina propria, where it colocalizes more with dendritic cells and macrophages. Basal levels of P2X7-R mRNA were higher in CD inflamed mucosa compared with noninflamed CD and controls and were upregulated after interferon-γ in controls. Apoptotic rates were higher in CD epithelium and lamina propria compared with ulcerative colitis and controls. Levels of tumor necrosis factor-α, interleukin (IL)-1β, and IL-17 were higher, whereas IL-10 was lower in CD compared with controls. Levels of tumor necrosis factor-α-α and interleukin-1β increased after adenosine-triphosphate and decreased after KN62 treatment in CD. P2X7-R animals did not develop trinitrobenzene sulfonic acid or DSS colitis.
CONCLUSIONS:
The upregulation of P2X7-R in CD inflamed mucosa is consistent with the involvement of purinoceptors in inflammation and apoptosis. These observations may implicate purinergic signaling in the pathogenesis of intestinal inflammation, and the P2X7-R may represent a novel therapeutic target in CD.
AuthorsAdriane R Neves, Morgana T L Castelo-Branco, Vanessa R Figliuolo, Claudio Bernardazzi, Fernanda Buongusto, Agnes Yoshimoto, Hayandra F Nanini, Claudia M L M Coutinho, Antonio José V Carneiro, Robson Coutinho-Silva, Heitor S P de Souza
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 20 Issue 3 Pg. 444-57 (Mar 2014) ISSN: 1536-4844 [Electronic] England
PMID24412990 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-1beta
  • RNA, Messenger
  • Receptors, Purinergic P2X7
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interferon-gamma
  • Adenosine Triphosphate
Topics
  • Adenosine Triphosphate (metabolism)
  • Adolescent
  • Adult
  • Animals
  • Apoptosis
  • Blotting, Western
  • Case-Control Studies
  • Colitis, Ulcerative (genetics, metabolism, pathology)
  • Colonoscopy
  • Crohn Disease (genetics, metabolism, pathology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique
  • Follow-Up Studies
  • Humans
  • Interferon-gamma (metabolism)
  • Interleukin-10 (genetics, metabolism)
  • Interleukin-1beta (genetics, metabolism)
  • Intestinal Mucosa (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Middle Aged
  • Prognosis
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Receptors, Purinergic P2X7 (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: